President Trump on Thursday claimed his recent “most favored nation” executive order could cause U.S. drug prices to “drop like a rock” in just a matter of weeks, saying ...

A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer ...

BMO Capital Markets reaffirmed its “Outperform” rating on Tourmaline Bio, Inc. (NASDAQ:TRML) with a price target of $35. The ...

Eikon Therapeutics, a Bay Area biotech startup with $1.1 billion in funding, is laying off dozens of employees and pointing ...

Company to present interim update from ENLIGHTED Phase 3 Study in LG UTUC following assessment of 50% of targeted total ...

Volastra Therapeutics, a clinical-stage cancer biotechnology company focused on chromosomal instability, today announced preliminary safety and efficacy data from its ongoing, first-in-human Phase ...

Serina also announced the departure of Remy Gross from its Board of Directors. Mr. Ledger stated, "Remy has been a trusted advisor to the team at Serina for many years. We thank Remy for his ...

Rapper Kid Cudi told a jury Sean "Diddy" Combs broke into his Los Angeles home after the hip-hop mogul found out he was ...

STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing a total deal value of $470 million.

The Trump administration has revoked a $44 million dollar grant intended for the Birmingham area to bolster Biotechnology ...

Nine states in the Southeast showed growth in bioscience employment and establishments from 2019 to 2023, according to 2024 ...